Movement Alert|Zoetis Falls 4.04% in Regular Trading, USDA approval for three-disease chicken vaccine failed to lift shares

Market Focus
Nov 19

On November 19, Zoetis fell 4.04% in Regular Trading, trading at $82.2101 per share with turnover of $28.1379 million.

The clearest recent catalyst was the company’s announcement that the US Department of Agriculture licensed Poulvac Procerta HVT-ND-ILT, a vector vaccine for chickens designed to protect against Marek's disease, Newcastle disease, and infectious laryngotracheitis. However, the approval did not improve market sentiment, with the stock also indicated lower earlier in the session.

Background factors may have limited the positive read-through. Zoetis reported September-quarter revenue of $2.39 billion, down 1% year over year, although adjusted EPS of $1.75 topped expectations and full-year revenue guidance was raised to $9.22 billion to $9.32 billion. Even with the product approval, investors appear to remain cautious on the durability of growth.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10